Loading…
Optimi Health Corp. is projected to decline to $4.99 by 2027, a -9% move from its current price of $5.51.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.34 | $5.51 | $5.69 | -0.03% |
| May 30 | $5.26 | $5.51 | $5.76 | -0.05% |
| May 31 | $5.21 | $5.51 | $5.82 | -0.08% |
| Jun 1 | $5.16 | $5.50 | $5.87 | -0.10% |
| Jun 2 | $5.12 | $5.50 | $5.91 | -0.13% |
| Jun 3 | $5.09 | $5.50 | $5.95 | -0.15% |
| Jun 4 | $5.06 | $5.50 | $5.98 | -0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.06 | $5.50 | $5.98 | -0.18% |
| Week 2 | $4.87 | $5.49 | $6.18 | -0.36% |
| Week 3 | $4.74 | $5.48 | $6.34 | -0.54% |
| Week 4 | $4.62 | $5.47 | $6.47 | -0.72% |
| Week 5 | $4.52 | $5.46 | $6.59 | -0.89% |
| Week 6 | $4.44 | $5.45 | $6.70 | -1.07% |
| Week 7 | $4.35 | $5.44 | $6.80 | -1.25% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Optimi Health Corp. Common Shares (OPTH) operates in the Healthcare sector as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners.
Optimi Health also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, and related drug products, as well as mushroom supplements derived from botanical sources for health and wellness markets. It sells its products through Amazon marketplace and distributors/brokers, as well as online.
Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Optimi Health Corp. Common Shares (OPTH) is a healthcare stock currently priced at $5.85, with a market capitalization of $18.87M and a rank of 4963. The company operates as a pharmaceutical and nutraceutical drug manufacturer in Canada, with a product scope including MDMA, psilocybin, psilocin, other psychedelic substances, and functional mushrooms.
The stock trades within a 30-day range of $4.57 to $7.50, with near-term support at $5.70 and resistance at $6.08. The near-term forecast for 2026 shows an average price of $5.85 (min $5.70, max $8.27) and a neutral sentiment, with an ROI of 0.
Longer-term forecasts move toward bullish in the 2030s and beyond, with 2030 averaging $7.32 (min $4.39, max $13.01, ROI 25.2), 2040 averaging $8.78 (min $3.95, max $19.83, ROI 50), and 2050 averaging $19.55 (min $8.80, max $44.97, ROI 234.2), all bearing a bullish sentiment.
A major level 0.0% above — losing it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 10.3% above — a clean break opens room to run.
A major ceiling 10.3% above — clearing it would confirm fresh momentum.
Key OPTH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.51 | $5.51 | $7.61 | 0% | Neutral | |
| $3.67 | $4.99 | $7.32 | -9% | Neutral | |
| $3.83 | $5.48 | $8.50 | -1% | Neutral | |
| $4.03 | $6.02 | $9.77 | +9% | Neutral | |
| $4.34 | $6.75 | $11.36 | +23% | Bullish | |
| $4.45 | $7.19 | $12.48 | +31% | Bullish | |
| $3.81 | $6.39 | $11.40 | +16% | Neutral | |
| $3.72 | $6.45 | $11.81 | +17% | Neutral | |
| $3.81 | $6.83 | $12.79 | +24% | Bullish | |
| $3.73 | $6.91 | $13.22 | +25% | Bullish | |
| $3.91 | $8.43 | $17.61 | +53% | Bullish | |
| $8.13 | $18.07 | $41.57 | +228% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.51 | $5.51 | $6.48 | +0.00% |
| June 2026 | $4.41 | $5.27 | $6.50 | -4.38% |
| July 2026 | $4.44 | $5.38 | $6.80 | +2.16% |
| August 2026 | $4.41 | $5.41 | $6.94 | +0.44% |
| September 2026 | $4.26 | $5.27 | $6.87 | -2.44% |
| October 2026 | $4.33 | $5.41 | $7.14 | +2.61% |
| November 2026 | $4.51 | $5.68 | $7.58 | +4.99% |
| December 2026 | $4.45 | $5.65 | $7.61 | -0.63% |
Click any year to see its month-by-month OPTH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, OPTH could reach as high as $7.61, with a base case around $5.51 and support toward $5.51 — roughly 0% from $5.51. Price action looks broadly range-bound.
Expect OPTH to range from $3.67 to $7.32 through 2027. The $4.99 average target implies a -9% move from current prices. That is -9% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The OPTH price prediction for 2028 points to an average of $5.48 (low $3.83, high $8.50) — a potential decline of -1% on today's $5.51. Price action looks broadly range-bound.
In 2029, OPTH is projected to trade between $4.03 and $9.77, averaging $6.02 — a potential gain of +9% from today's $5.51. That is up +10% on the projected 2028 average. A consolidation phase looks the most probable path here.
Optimi Health Corp.'s 2030 outlook centres on $6.75, within a $4.34 to $11.36 range. That is up +12% on the projected 2029 average. That marks a +23% change versus current levels. Momentum favours further upside here.
By 2031, OPTH could reach as high as $12.48, with a base case around $7.19 and support toward $4.45 — roughly +31% from $5.51. Buyers look set to stay in control over this stretch.
Expect OPTH to range from $3.81 to $11.40 through 2032. The $6.39 average target implies a +16% move from current prices. That is -11% versus the projected 2031 average. Price action looks broadly range-bound.
The OPTH price prediction for 2033 points to an average of $6.45 (low $3.72, high $11.81) — a potential gain of +17% on today's $5.51. A consolidation phase looks the most probable path here.
In 2034, OPTH is projected to trade between $3.81 and $12.79, averaging $6.83 — a potential gain of +24% from today's $5.51. That is up +6% on the projected 2033 average. Momentum favours further upside here.
Optimi Health Corp.'s 2035 outlook centres on $6.91, within a $3.73 to $13.22 range. That is up +1% on the projected 2034 average. That marks a +25% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, OPTH could reach as high as $17.61, with a base case around $8.43 and support toward $3.91 — roughly +53% from $5.51. Momentum favours further upside here.
Expect OPTH to range from $8.13 to $41.57 through 2050. The $18.07 average target implies a +228% move from current prices. That is up +114% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OPTH today (≈ 181.488203 OPTH) could be worth
$3,280.36
+$2,280.36 (+228%) by 2050 · US Dollar
Based on the average projected OPTH price of $18.07 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPTHwould be worth at today's price.
$1,000 invested in OPTH on May 20, 2026 (≈ 164.473686 OPTH) would be worth
$906.25
-$93.75 (-9.4%) today · 0.91× · US Dollar
Based on a OPTH entry price of $6.08 vs. today's $5.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.08 | $906.25 | -9.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPTH forecast.
Our base-case forecast reaches $11.00 around 2050.
Implied market cap at $11.00: $61.88M
The multi-year forecast shows a shift from neutral to bullish sentiment over time. In 2030 the average forecast price is $7.32 with a max of $13.01 and a min of $4.39, delivering an ROI of 25.2 and a bullish stance.
In 2040 the average is forecast at $8.78 with a max of $19.83 and a min of $3.95, delivering an ROI of 50 and a bullish stance. In 2050 the average is forecast at $19.55 with a max of $44.97 and a min of $8.80, delivering an ROI of 234.2 and a bullish stance.
These forecasts are estimates and not guarantees. They should be considered in the context of potential volatility and market risk for a small-cap healthcare/pharmaceutical equities.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $7.32 with a min of $4.39 and a max of $13.01, and an ROI of 25.2; sentiment is BULLISH.
Near-term outlook in 2026 shows an average of $5.85 with a range of $5.70 to $8.27 and neutral sentiment. Longer-term forecasts turn bullish by 2030 (avg $7.32; ROI 25.2) and extend to 2050 (avg $19.55; ROI 234.2), but these are estimates, not guarantees.
No. The 2050 forecast max is $44.97, which does not reach $50.
The near-term forecast for 2026 shows an average price of $5.85 with a 30-day range of $4.57 to $7.50, supported by $5.70 and resisted by $6.08.
2030: avg $7.32 (max $13.01, min $4.39; ROI 25.2; sentiment BULLISH). 2040: avg $8.78 (max $19.83, min $3.95; ROI 50; sentiment BULLISH). 2050: avg $19.55 (max $44.97, min $8.80; ROI 234.2; sentiment BULLISH). These are estimates, not guarantees.
Optimi Health Corp. Community Discussion
0Share your Optimi Health Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.